认知和运动障碍与功能能力和依赖性在亨廷顿病的具体贡献
Andres Gil-Salcedo1,2,3,4, Marine Lunven5,6,7,8, Charlotte Jacquemot5,7,9
1Département d'Études Cognitives, École Normale Supérieure, PSL University, 75005, Paris, France. andres.gil-salcedo@inserm.fr.
Journal of neurology
|February 22, 2025
概括
运动和认知障碍在亨廷顿病 (HD) 中显著影响日常功能. 运动缺陷比认知缺陷,特别是执行功能,对保持患者的自主性有更强的影响.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 人类遗传学 人类遗传学
背景情况:
- 亨廷顿病 (HD) 是一种进展性神经退行性疾病,其特点是运动,认知和精神缺陷.
- 这些缺陷导致了日益增长的依赖和减少日常活动中的自主权.
- 解开运动与认知障碍对功能的具体影响是具有挑战性的,因为它们在HD中的相互联系.
研究的目的:
- 确定运动和认知障碍对亨廷顿病功能能力的独立贡献.
- 评估对日常生活的基本活动 (ADL),日常生活的工具性活动 (IADL) 和与工作有关的活动 (WRA) 的影响.
主要方法:
- 158名亨廷顿病 (HD) 突变携带者使用统一亨廷顿病评分表和SelfCog认知评估工具进行了评估.
- SelfCog工具允许单独评估运动处理和各种认知领域 (记忆,语言,执行功能,视觉空间处理).
- 使用线性和逻辑回归来分析运动/认知障碍与功能能力/依赖之间的关联.
主要成果:
- 运动和认知障碍都独立地与HD患者的功能能力下降有关,运动表现显示出更强的相关性.
- 所有评估的认知领域都对功能衰退做出了贡献,执行功能和全球认知分数显示出最显著的关联.
- 全球和执行认知功能的较大缺陷增加了ADL,IADL和WRA中依赖的风险.
结论:
- 运动障碍,其次是认知缺陷 (尤其是执行功能),独立地导致亨廷顿病的功能衰退.
- 这些发现凸显了针对运动和认知领域的有针对性的干预措施的必要性,以提高患有HD的个体的自主性和生活质量.
更多相关视频
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
7.7K
07:35Author Spotlight: Rehabilitation of Stroke Patients With a Digital Occupational Training System
Published on: December 29, 2023
1.1K
相关概念视频
01:14Role of Cerebellum and Prefrontal Cortex in Memory
335
The cerebellum, while traditionally associated with motor control, also plays a crucial role in memory, particularly in procedural memory, which involves learning motor tasks that become automatic through repetition. For example, studies have shown that when the cerebellum is damaged, individuals or animals lose the ability to learn conditioned motor responses, such as the conditioned eye-blink response in classical conditioning experiments with rabbits. This study demonstrates the...
335
01:15Parkinson's Disease: Overview
424
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
424